Dendritic cells: inciting and inhibiting autoimmunity - PubMed (original) (raw)

Review

Dendritic cells: inciting and inhibiting autoimmunity

Shannon J Turley. Curr Opin Immunol. 2002 Dec.

Abstract

Dendritic cells are considered the most influential antigen presenting cells in the body because of their unique role in initiating immunity against threatening antigens. Recent studies addressing the consequences of self-antigen presentation by dendritic cells revealed the unexpected ability of these antigen presenting cells to inhibit T cell-mediated autoimmune diseases. The specific mechanisms by which dendritic cells suppress immune responses have been explored during the past year. These efforts indicate that extrathymic dendritic cells control autoimmunity by inducing peripheral T cell tolerance, a function intimately linked to their state of maturation.

PubMed Disclaimer

Similar articles

• Dendritic cells and autoimmunity.
  Bayry J, Thirion M, Delignat S, Misra N, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Bayry J, et al. Autoimmun Rev. 2004 Mar;3(3):183-7. doi: 10.1016/S1568-9972(03)00104-6. Autoimmun Rev. 2004. PMID: 15110229 Review.
• The Importance of Dendritic Cells in Maintaining Immune Tolerance.
  Audiger C, Rahman MJ, Yun TJ, Tarbell KV, Lesage S. Audiger C, et al. J Immunol. 2017 Mar 15;198(6):2223-2231. doi: 10.4049/jimmunol.1601629. J Immunol. 2017. PMID: 28264998 Free PMC article. Review.
• The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis.
  Iruretagoyena MI, Wiesendanger M, Kalergis AM. Iruretagoyena MI, et al. Curr Pharm Des. 2006;12(2):131-47. doi: 10.2174/138161206775193145. Curr Pharm Des. 2006. PMID: 16454731 Review.
• Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?
  Pettit AR, Thomas R. Pettit AR, et al. Immunol Cell Biol. 1999 Oct;77(5):420-7. doi: 10.1046/j.1440-1711.1999.00855.x. Immunol Cell Biol. 1999. PMID: 10540208 Review.
• [Preservation of immune tolerance to avoid autoimmunity. The role of dendritic cells].
  Lutz MB. Lutz MB. Hautarzt. 2003 Sep;54(9):894-6. doi: 10.1007/s00105-003-0612-4. Hautarzt. 2003. PMID: 14575032 German. No abstract available.

Cited by

• Activation of T cell checkpoint pathways during β-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes.
  Gudi RR, Perez N, Karumuthil-Melethil S, Li G, Vasu C. Gudi RR, et al. Immunology. 2022 Jul;166(3):341-356. doi: 10.1111/imm.13476. Epub 2022 Apr 22. Immunology. 2022. PMID: 35404483 Free PMC article.
• The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine.
  Sun J, Shi J, Li J, Wu M, Li Y, Jia S, Ma C, Wang X, Li Z, Hu N, Hu Y. Sun J, et al. Front Immunol. 2021 Jul 7;12:681328. doi: 10.3389/fimmu.2021.681328. eCollection 2021. Front Immunol. 2021. PMID: 34305913 Free PMC article.
• Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance.
  Gudi RR, Karumuthil-Melethil S, Perez N, Li G, Vasu C. Gudi RR, et al. Sci Rep. 2019 Aug 19;9(1):12065. doi: 10.1038/s41598-019-48464-y. Sci Rep. 2019. PMID: 31427630 Free PMC article.
• DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.
  Price JD, Hotta-Iwamura C, Zhao Y, Beauchamp NM, Tarbell KV. Price JD, et al. Diabetes. 2015 Oct;64(10):3521-31. doi: 10.2337/db14-1880. Epub 2015 Jun 12. Diabetes. 2015. PMID: 26070317 Free PMC article.
• FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis.
  Ramos MI, Perez SG, Aarrass S, Helder B, Broekstra P, Gerlag DM, Reedquist KA, Tak PP, Lebre MC. Ramos MI, et al. Arthritis Res Ther. 2013;15(6):R209. doi: 10.1186/ar4403. Arthritis Res Ther. 2013. PMID: 24314260 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal